Gilhuly Accelerator Fund
The Gilhuly Accelerator Fund, managed by Duke’s Office for Translation and Commercialization, aims to position Duke innovations for maximum commercial and societal impact by providing support to accelerate the path from research and innovation to commercial development. The Fund is available for any Duke owned innovation and can be used to support asset development and de-risking activities spanning early proof-of-concept demonstrations to later-stage translational regulatory and validationmarket studies. Projects are selected on a rolling-basis by an oversight committee, comprised of OTC leadership and external advisors. Project selection criteria include scientific merit, addressable commercial market , strength of IP, and potential for follow-on funding/licensing via existing industry partners or new startup formation. Funds are provided for direct costs only and may not be used for capital equipment purchases or tuition support but may be used to pay for external services and service providers. Any personnel support is limited to salary and stipend support for staff, students and postdocs who are directly involved in the funding activities.
Four Points Innovation
A strategic partnership between Duke and Deerfield Managed, launched in 2019 to support and accelerat the translation of research into new therapies to treat and cure society’s most formidable healthcare challenges. Through this partnership, Deerfield will fund Four Points Innovation up to $130 million and provide development expertise in support of Duke’s innovative drug research across a span of high-need therapeutic areas.
Translational Program Partners
Since 2006, Duke's translational partnership with the Wallace H. Coulter Foundation has supported collaborative research projects that address unmet clinical needs and lead to improvements in health care and to commercial products.
Learn more about the Coulter PartnershipThe CTSI is the administrative home for the Duke Clinical and Translational Science Award (CTSA), overseeing and integrating sixteen CTSA core services into the fabric of translational science at Duke University.
Learn More about CTSIThe mission of the Duke Institute for Health Innovation (DIHI) is to catalyze transformative innovations in health and healthcare, and to help cultivate a community of innovation and entrepreneurship across Duke University and the health enterprise.
Learn more about DIHIDuke Innovation & Entrepreneurship inspires and empowers students to act entrepreneurially in all their endeavors.
I&E serves students across Duke, connecting them to courses, co-curricular programs, mentoring, resources, community, and intellectual leadership.
Learn More about I&EGrant funding from the North Carolina Biotechnology Center (NCBio) fills critical funding gaps along the innovation continuum – from building university infrastructure to supporting early-stage development of university inventions to help move technology toward commercialization.
NCBio offers multiple funding mechanisms that are available to university investigators and startup companies.
Learn more about NCBio Funding ProgramsLearn more about other programs and opportunities that provide funding and capital to inventors and startups.,
Funding and Capital ResourcesFunding Opportunities
View a listing of current available funding opportunities.
-
Nucleate – Activator Program Apps Open – Sep 26 info session
Nucleate is a student-run nonprofit organization that facilitates the formation of new life science ventures.